(Q44618813)

English

Fatal cholestatic liver failure associated with gemcitabine therapy

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Fatal cholestatic liver failure associated with gemcitabine therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

author name string

Keith Robinson

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Louis Lambiase

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Jianjun Li

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Carmela Monteiro

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Michael Schiff

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1804-1808

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

https://scigraph.springernature.com/pub.10.1023/a:1025415616592

0 references

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Veno-occlusive disease of the liver induced by gemcitabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Herbs as medicines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute hepatic failure: a Western perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Phase I study of gemcitabine hydrochloride (LY 188011) combination therapy with cisplatin in the patients with non-small cell lung cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complementary medicine--where lies its appeal?

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dextropropoxyphene induced hepatotoxicity: a report of nine cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal thrombocytopenia and liver failure associated with carboplatin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A fatal case of cholestatic liver failure probably related to gemcitabine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etiology and outcome for 295 patients with acute liver failure in the United States.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternative medicine--the risks of untested and unregulated remedies

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chinese herbal medicines revisited: a Hong Kong perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/14561005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1025415616592

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44618813&oldid=2029524371"